In a world of increasing fragmentation and polarisation, the 78th World Health Assembly, starting Monday, will present itself ...

The global drug delivery technology market is on a transformative trajectory, projected to soar from USD 52.1 billion in 2025 to an astounding USD 136.7 billion by 2035. This reflects a robust CAGR of ...

While the clearance is only for use in certain groups, Novavax’s long-awaited OK is still seen by analysts as a “win” for the ...

China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...

Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine, and shares jumped 25% at the opening bell Monday.

The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Novavax finally won approval of a Covid-19 vaccine after facing setback after setback that caused the stock to plunge more ...

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.

When President Donald Trump announced the lifting of US sanctions on Syria during his trip to the Middle East this week, it ...